BioSpace News Archive

C3i partners with Paladin Labs Inc. to offer Canadian clinicians a complimentary testing service to detect T315I mutation

C3i Center Inc and Paladin Labs Inc., a subsidiary of Endo International plc, have partnered to launch a complimentary clinical testing program for the diagnosis of the T315I mutation in Philadelphia chromosome-positive chronic myeloid leukemia and acute lymphoblastic leukemia patients in Canada.

June 12, 2023
·
2 min read
Achilles Therapeutics to Present at Upcoming June 2023 Conferences

Achilles Therapeutics plc, a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies to treat solid tumors, announced that the Company will be taking part in the following conferences in June.

June 12, 2023
·
2 min read
BioMidwest

Creative Medical Technology Holdings Provides Corporate Update

Creative Medical Technology Holdings, Inc., a biotechnology company focused on a regenerative approach to immunotherapy, endocrinology, urology, gynecology, and orthopedics, provided an update on recent business activities.

June 12, 2023
·
6 min read
BioMidwest

Creative Medical Technology Announces $2 Million Share Repurchase Program

Creative Medical Technology Holdings, Inc., a biotechnology company focused on a regenerative approach to immunotherapy, endocrinology, urology, gynecology, and orthopedics, announced that its Board of Directors has approved a share repurchase program.

June 12, 2023
·
2 min read
BioForest

Many long COVID patients suffer from persistent inflammation, study finds

An overactive inflammatory response could be at the root of many long COVID cases, according to a new study from the Allen Institute and Fred Hutchinson Cancer Center.

June 12, 2023
·
5 min read
Resverlogix Announces New Insights into the Mechanism of Apabetalone’s Cardioprotective Benefit in Chronic Kidney Disease Patients

Resverlogix Corp. (TSX: RVX) (“Resverlogix”) today announced a peer-reviewed article, entitled, “Apabetalone Downregulates Fibrotic, Inflammatory and Calcific Processes in Renal Mesangial Cells and Patients with Renal Impairment,”

June 12, 2023
·
5 min read
Smith+Nephew announces 510(k) clearance of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its AETOS Shoulder System.

June 12, 2023
·
6 min read
Drug Development

Aardvark Therapeutics Reports Positive Phase II Clinical Data for ARD-101

Aardvark Therapeutics, Inc., a clinical stage biopharmaceutical company, today reported positive clinical data from three Phase II trials for its lead program ARD-101, an oral small molecule bitter taste receptor (TAS2R) agonist.

June 12, 2023
·
4 min read
FDA

Ironwood Pharmaceuticals Announces FDA Approval of New Indication for LINZESS® (linaclotide) for the Treatment of Functional Constipation in Pediatric Patients Ages 6-17 Years-Old

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has approved LINZESS® (linaclotide) as a once-daily treatment for pediatric patients ages 6-17 years-old with functional constipation.

June 12, 2023
·
11 min read
Bio NC

Fennec Announces Results of Annual Meeting - June 12, 2023

Fennec Pharmaceuticals Inc. announced that the nominees listed in the management proxy circular dated April 24, 2023 for the Annual General Meeting of Shareholders were elected as directors of the Company at the Annual General Meeting of Shareholders held in New York, New York on June 12, 2023.

June 12, 2023
·
1 min read